期刊文献+

肝肾疾病对血浆同型半胱氨酸水平的影响 被引量:2

The Effect of Hepatic and Renal Diseases on Plasma Homocysteine Level
下载PDF
导出
摘要 目的探讨肝脏和肾脏在同型半胱氨酸(Hcy)代谢中的作用.方法选择健康正常人55例,肝硬化患者72例,慢性肾功能不全患者61例以及肝硬化合并肝肾综合征患者18例.血浆Hcy检测用高效液相色谱法.结果与对照组相比,肝硬化组、慢性肾功能不全组以及肝肾综合征组的血浆Hcy浓度均显著升高;肝肾综合征组血浆Hcy浓度显著高于肝硬化组或慢性肾功能不全组(P<0.01).结论肝脏和肾脏在Hcy的清除中均起重要作用,肝脏和肾脏功能受损均可造成血浆Hcy水平升高. Objective To study the role of liver and kidney in catabolism of homocysteine (Hcy). Methods 55 healthy volunteers, 72 patients with hepatic cirrhosis, 61 patients with chronic renal failure and 18 patients with hepatic cirrhosis as well as hepatorenal syndrome were included in this study. The concentration of plasma Hcy was determined by using high - pressure liquid chromatography. Results The levels of plasma Hcy in patients with hepatic cirrhosis, chronic renal failure and hepatorenal syndrome markedly increased, compared with that of the control group. The concentration of plasma Hcy in patients with hepatorenal syndrome was significantly higher than those in patients with either hepatic cirrhosis or chronic renal failure. Conclusion Insult in either hepatic or renal functions results in an increase in plasma Hcy. Thus, both liver and kidney play important roles in clearance of Hcy.
出处 《昆明医学院学报》 2007年第2期99-101,107,共4页 Journal of Kunming Medical College
关键词 同型半胱氨酸 肝硬化 慢性肾功能不全 肝肾综合征 Homocysteine Hepatic cirrhosis Chronic renal failure Hepatorenal syndrome
  • 相关文献

参考文献9

  • 1LENTZ S R.Homocysteine and vascular dysfunction[J].Life Sci,1997.61:1205—1215.
  • 2BOSY-WESTPHAL A,PETERSEN S,HINRICHSEN H,et al.Increased plasma homocysteine in liver cirrhosis[J].Hepatol Res,2001.20:28—38.
  • 3LESKINEN Y, LEHTIMAKI T, LOIMAALA A, et al.Homocysteine and carotid atherosclerosis in chronic renal failure - the confounding effect of renal function[J]. Atherosclerosis, 2004, 175:315-323.
  • 4FEUSSNER A, ROLINSKI B, WEISS N, et al. Determination of total homocysteine in human plasma by isocratic high - performance liquid chromatography [ J ].Eur J Clin Chem Clin Biochem, 1997, 35:687 -691.
  • 5ZOU C - G, BANERJEE R. Homocysteine and redox signaling [J]. Antioxid Redox Signal, 2005, 7 (5-6) : 547 - 559.
  • 6WAODEK P J, SMOLENSKI O B, CHWATKO G, et al. Disruption of thiol homeostasis in plasma of terminal renal failure patients [ J ]. Clinica Chimica Acta,2006, 366:137 - 145.
  • 7石胜,陈健勇,黄华兴,卢岑.血浆同型半胱氨酸水平与肝硬化严重程度的相关性研究[J].实用医学杂志,2004,20(5):530-531. 被引量:19
  • 8GARCIA -TEVIJANO E R, BERASAIN C, RODRIGUEZ J A, et al. Hyperhomocysteinemia in liver cirrhosis: mechanisms and role in vascular and hepatic fibrosis [J]. Hypertension, 2001, 38:1217-1221.
  • 9VARELA - MOREIRAS G, ALONSO - APERTE E,RUBIO M, et al. Carbon tetrachloride -induced hepatic injury is associated with global DNA hypomethylation and homocysteinemia: effect of S - adenosylmethionine treatment [J]. Hepatology, 1995, 22 (4) :1310 - 1315.

二级参考文献6

  • 1Guba SC, Fink LM, Fonseca V. Hyperhomocysteinemia - an emerging and important risk factor for thromboembolic and cardiovascular disease.AM J Clin Pathol, 1996, 106(6):709-722
  • 2Houseton PE, Rana S, Sekhsaria S, et al. Homocysteine in sickle cell disease: relationship to stroke. AM J Med, 1997, 103(3):192- 196
  • 3Graham TM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. JAMA, 1997, 277(22):1775 - 1781
  • 4Mayer EL, Jacobsen DM, Robinson K. Homocysteine and coronary atheroselcrosis. JACC, 1996, 27(3) :517 - 527
  • 5Stead LM, Brosnan ME, Brosnan JT. Characterization of homocysteine metabolism in the rat liver. Biochem J, 2000, 350(3) :685 - 692
  • 6Garcia-Tevijano ER, Berasain C, Rodriguez JA, et al. Hyperhomocysteinemia in liver cirrhosis: mechanisms and role in vascular and hepatic fibrosis. Hypertension, 2001, 38(5): 1217 - 1221

共引文献18

同被引文献22

  • 1莫丽亚,黄彩芝,蒋玉莲,黎赛.智力低下小儿血同型半胱氨酸水平检测及意义[J].中国医师杂志,2005,7(11):1566-1567. 被引量:7
  • 2孙博谦,李威,李昕华.高同型半胱氨酸血症致脑血管病机制研究[J].中国康复医学杂志,2007,22(7):638-639. 被引量:8
  • 3LENTZ S R. Homocysteine and vascular dysfunction[J].Life Sci, 1997,61 : 1205 - 1215
  • 4REFSUM H, UELAND P M, NYGARD O, et al. Homocysteine and cardiovascular disease [ J ]. Annu Rev Med, 1998,4-9:31 - 62
  • 5ZOU C G, BANERJEE R. Homocysteine and redox signaling [J]. Antioxid Redox Signal,2005,7(5 - 6) : 547 -559.
  • 6ELA-MOREIRAS G, ALONSO-APERTE E, VARRUBIO M, et al. Carbon tetrachloride-induced hepatic injury is associated with global DNA hypomethylation and homocysteinemia:effect of S-adenosylmethionine treatment [J]. Hepatology, 1995,22(4) : 1310 - 1315
  • 7BOSY-WESTPHAL A, PETERSEN S, HINRICHSEN H, et al. Increased plasma homocysteine in liver cirrhosis [J]. Hepatol Res,2001,20:28 - 38
  • 8GARCIA-TEVIJANO E R, BERASAIN C, ROD- RIGUEZ J A,et al. Hyperhomocysteinemia in liver cirrhosis Mechanisms and role in vascular and hepatic fibrosis [ J ]. Hypertension, 2001,38 : 1217 - 1221
  • 9ZOU C G, BANERJEE R. Tumor necrosis factor -induced targeted proteolysis of cystathionine beta-synthase modulates redox homeostasis[J]. J Biol Chem, 2003,278 : 16802 - 16808
  • 10ROBERT K, CHASSE J F, SANTIARD-BARON D, et al. Altered gene expression in liver from a murine model of hyperhomocysteinemia[J].J Biol Chem,2003,278:31501- 31511

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部